INOVA FAIRFAX HOSPITAL
The Sunshine Act requires manufacturers to report payments to teaching hospitals as institutions, separately from payments to individual physicians. These figures are money reported to the hospital itself — most of it research funding and grants, not compensation to any named doctor.
- Total reported
- $54.5M
- Transactions
- 4,916
- Companies
- 40
- Average per transaction
- $11,082
Who reported the payments
| Merck | $19,690,140 |
| E.r. Squibb & Sons, L.L.C. | $3,960,448 |
| Gilead | $3,403,262 |
| Regeneron | $3,145,528 |
| Pfizer | $1,381,940 |
| Abbott | $1,219,131 |
| Ortho-clinical Diagnostics, Inc. | $1,192,126 |
| Roche Diagnostics Corporation | $1,119,043 |
| Seagen Inc. | $1,088,614 |
| Mimedx Group, Inc. | $852,000 |
| Genentech, Inc. | $768,922 |
| Jazz Pharmaceuticals Inc. | $720,270 |
| AbbVie | $711,287 |
| Incyte Corporation | $675,118 |
| Roche Molecular Systems, Inc. | $637,706 |
| Sumitomo Pharma America, Inc. | $609,914 |
| Medtronic | $551,510 |
| Stryker | $550,916 |
| Roche Diagnostics Operations, Inc. | $544,324 |
| Siemens Medical Solutions USA, Inc. | $521,557 |
| Novartis | $514,244 |
| New York Blood Center, Inc. | $464,829 |
| Boston Scientific | $464,532 |
| Amgen | $461,337 |
| Janssen Research & Development, LLC | $459,757 |
| Edwards Lifesciences | $429,296 |
| Intercept Pharmaceuticals, Inc. | $420,131 |
| CSL Behring | $348,115 |
| Mirati Therapeutics, Inc. | $323,298 |
| Syndax Pharmaceuticals, Inc. | $305,305 |
| Rigel Pharmaceuticals, Inc. | $305,237 |
| Intuitive Surgical | $284,422 |
| Novo Nordisk AS | $284,009 |
| Radius Health, Inc. | $275,335 |
| Pulmonx Corporation | $252,782 |
| Stemline Therapeutics Inc. | $245,117 |
| Roche Products Limited | $214,981 |
| Biontech SE | $197,169 |
| Bayer | $181,551 |
| Biosense Webster, Inc. | $178,648 |